Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 Harmony Study of Pegtibatinase Related to Commercial Manufacturing Scale-up
Travere Therapeutics宣佈暫停Pegtibatinase第3期Harmony研究的自願招募,與商業製造規模擴大有關
Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 Harmony Study of Pegtibatinase Related to Commercial Manufacturing Scale-up
Travere Therapeutics宣佈暫停Pegtibatinase第3期Harmony研究的自願招募,與商業製造規模擴大有關
譯文內容由第三人軟體翻譯。